EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

De-Suppression of Mesenchymal Cell Identities and Variable Phenotypic Outcomes Associated with Knockout of Bbs1

Grace Mercedes Freke, Tiago Martins, Rosalind Jane Davies, Tina Beyer iD, Marian Seda iD, Emma Peskett, Naila Haq iD, Avishek Prasai, Georg Otto iD, Jeshmi Jeyabalan Srikaran iD, Victor Hernandez iD, Gaurav D Diwan und 6 weitere

Cells · 2023

DOI: 10.3390/cells12222662 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, 2023. Verfasst von Grace Mercedes Freke und 17 weiteren Autor:innen. Beteiligte Einrichtung: Great Ormond Street Institute of Child Health, University College London, London WC1N 1EH, UK. Hauptthemen laut MEDLINE: Bardet-Biedl Syndrome. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, Medical Research Council, Czech Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bardet–Biedl syndrome (BBS) is an archetypal ciliopathy caused by dysfunction of primary cilia. BBS affects multiple tissues, including the kidney, eye and hypothalamic satiety response. Understanding pan-tissue mechanisms of pathogenesis versus those which are tissue-specific, as well as gauging their associated inter-individual variation owing to genetic background and stochastic processes, is of paramount importance in syndromology. The BBSome is a membrane-trafficking and intraflagellar transport (IFT) adaptor protein complex formed by eight BBS proteins, including BBS1, which is the most commonly mutated gene in BBS. To investigate disease pathogenesis, we generated a series of clonal renal collecting duct IMCD3 cell lines carrying defined biallelic nonsense or frameshift mutations in Bbs1, as well as a panel of matching wild-type CRISPR control clones. Using a phenotypic screen and an unbiased multi-omics approach, we note significant clonal variability for all assays, emphasising the importance of analysing panels of genetically defined clones. Our results suggest that BBS1 is required for the suppression of mesenchymal cell identities as the IMCD3 cell passage number increases. This was associated with a failure to express epithelial cell markers and tight junction formation, which was variable amongst clones. Transcriptomic analysis of hypothalamic preparations from BBS mutant mice, as well as BBS patient fibroblasts, suggested that dysregulation of epithelial-to-mesenchymal transition (EMT) genes is a general predisposing feature of BBS across tissues. Collectively, this work suggests that the dynamic stability of the BBSome is essential for the suppression of mesenchymal cell identities as epithelial cells differentiate.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bardet-Biedl SyndromeHumansMiceAnimalsMice, KnockoutProteinsCiliaMicrotubule-Associated Proteins

Stichwörter der Autor:innen

Bardet–Biedl syndromeWnt signallingcollecting duct cellsepithelial-to-mesenchymal transitionfibrosiskidneyprimary cilia

Substanzen

ProteinsBbs1 protein, humanMicrotubule-Associated ProteinsBbs1 protein, mouse

Autor:innen und Institutionen

  • Great Ormond Street Institute of Child Health, University College London, London WC1N 1EH, UK.
  • Institute for Ophthalmic Research, Center for Ophthalmology, University of Tübingen, Elfriede-Aulhorn-Strasse 7, 72076 Tübingen, Germany.
  • Laboratory of Adaptive Immunity, Institute of Molecular Genetics of the Czech Academy of Sciences, 14220 Prague, Czech Republic.
  • Life Sciences Department, CHMLS, Brunel University London, Kingston Lane, Uxbridge UB8 3PH, UK.
  • BioQuant, University of Heidelberg, Im Neuenheimer Feld 267, 69120 Heidelberg, Germany.
  • Biochemistry Center (BZH), University of Heidelberg, Im Neuenheimer Feld 328, 69120 Heidelberg, Germany.

ORCID-Profile: Tina Beyer, Marian Seda, Naila Haq, Georg Otto, Jeshmi Jeyabalan Srikaran, Victor Hernandez, Marius Ueffing, Martina Huranova, Karsten Boldt, Philip L Beales

Förderung

  • Wellcome Trust
  • Medical Research Council
  • Czech Science Foundation

Zitieren

APA

Freke, G. M., Martins, T., Davies, R. J., Beyer, T., Seda, M., Peskett, E., Haq, N., Prasai, A., Otto, G., Jeyabalan Srikaran, J., Hernandez, V., Diwan, G. D., Russell, R. B., Ueffing, M., Huranova, M., Boldt, K., Beales, P. L., & Jenkins, D. (2023). De-Suppression of Mesenchymal Cell Identities and Variable Phenotypic Outcomes Associated with Knockout of Bbs1. Cells. https://doi.org/10.3390/cells12222662

Vancouver

Freke GM, Martins T, Davies RJ, Beyer T, Seda M, Peskett E, et al. De-Suppression of Mesenchymal Cell Identities and Variable Phenotypic Outcomes Associated with Knockout of Bbs1. Cells. 2023. doi:10.3390/cells12222662

BibTeX
@article{Freke2023,
  author = {Freke, Grace Mercedes and Martins, Tiago and Davies, Rosalind Jane and Beyer, Tina and Seda, Marian and Peskett, Emma and Haq, Naila and Prasai, Avishek and Otto, Georg and Jeyabalan Srikaran, Jeshmi and Hernandez, Victor and Diwan, Gaurav D and Russell, Robert B and Ueffing, Marius and Huranova, Martina and Boldt, Karsten and Beales, Philip L and Jenkins, Dagan},
  title = {De-Suppression of Mesenchymal Cell Identities and Variable Phenotypic Outcomes Associated with Knockout of Bbs1},
  journal = {Cells},
  year = {2023},
  doi = {10.3390/cells12222662}
}
Kostenlos starten →